Puma Biotechnology Inc (PBYI) Annual Balance Sheets

Annual · GAAP · USD millions
Access PBYI quarterly Balance Sheets →
The balance sheet data below highlights changes in Puma Biotechnology Inc's financial position over recent quarters.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent29.64
Marketable Securities, Current SH67.89
Cash & Short-term Investments96.00
Accounts receivable53.65
Inventories5.52
Other Current Assets2.35
Prepaid Expense, Current AS3.64
Total Current Assets162.69
Equipment/Property/Plant Net0.19
Intangible Assets41.39
Tax Assets, Noncurrent0.00
Deferred, Prepaid and Other Assets, Noncurrent0.00
Other Assets, Noncurrent12.04
Total Assets216.30
Liabilities
Accounts Payable, Current AC5.06
Accrued Liabilities, Current AC50.03
Long-term Debt, Current Maturities LO22.52
Other Liabilities, Current3.64
Taxes Payable0.00
Total Current Liabilities81.25
Long-term debt0.00
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent0.00
Total Liabilities85.96
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1,414.07
Retained Earnings / Accumulated Deficit-1,283.78
Accumulated Other Comprehensive Income0.00
Other Equity0.04
Common Stockholder's Equity130.34
Total Stockholder's Equity130.34
Liabilities & Stockholder's Equity216.30
4 historic quarters locked

Sign in to unlock the full Puma Biotechnology Inc balance sheet history.

About Puma Biotechnology Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-26-005891

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.